Cargando…
Nanoparticle-based drug delivery systems for the treatment of cardiovascular diseases
Cardiovascular disease is the most common health problem worldwide and remains the leading cause of morbidity and mortality. Despite recent advances in the management of cardiovascular diseases, pharmaceutical treatment remains suboptimal because of poor pharmacokinetics and high toxicity. However,...
Autores principales: | Yang, Fangyu, Xue, Jianjiang, Wang, Guixue, Diao, Qizhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512262/ https://www.ncbi.nlm.nih.gov/pubmed/36172197 http://dx.doi.org/10.3389/fphar.2022.999404 |
Ejemplares similares
-
Nanoparticle drug delivery systems for synergistic delivery of tumor therapy
por: Chen, Daoyuan, et al.
Publicado: (2023) -
Pharmacokinetic Aspects of Nanoparticle-in-Matrix Drug Delivery Systems for Oral/Buccal Delivery
por: Feitosa, Renata Carvalho, et al.
Publicado: (2019) -
Bone-Targeted Nanoparticle Drug Delivery System: An Emerging Strategy for Bone-Related Disease
por: Chen, Yulin, et al.
Publicado: (2022) -
Editorial: Bone targeting nanoparticle drug delivery system in bone metabolism and bone-related tumor diseases
por: Wang, Xing, et al.
Publicado: (2022) -
Targeting Lymphatics for Nanoparticle Drug Delivery
por: McCright, Jacob, et al.
Publicado: (2022)